Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Recruiting Phase 2 Interventional

A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis

ClinicalTrials.gov ID: NCT06975722

Public ClinicalTrials.gov record NCT06975722. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 18, 2026, 4:49 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2b, Multi-national, Multi-center, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study Followed by a Long-term Extension to Evaluate the Efficacy and Safety of SAR442970 in Adult Participants With Moderate to Severe Ulcerative Colitis

Study identification

NCT ID
NCT06975722
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Sanofi
Industry
Enrollment
99 participants

Conditions and interventions

Conditions

Not listed

Interventions

Not listed

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 6, 2025
Primary completion
Dec 16, 2026
Completion
Oct 16, 2029
Last update posted
Apr 22, 2026

2025 – 2029

United States locations

U.S. sites
21
U.S. states
12
U.S. cities
20
Facility City State ZIP Site status
Investigational Site Number: 8400009 Escondido California 92025 Recruiting
Investigational Site Number: 8400006 Lancaster California 93534 Recruiting
Investigational Site Number: 8400025 Thousand Oaks California 91360 Recruiting
Investigational Site Number: 8400024 Jacksonville Florida 32258 Recruiting
Investigational Site Number: 8400030 Kissimmee Florida 347441 Recruiting
Investigational Site Number: 8400003 Lighthouse PT Florida 33064 Recruiting
Investigational Site Number: 8400001 Miami Florida 33134 Recruiting
Investigational Site Number: 8400011 Miami Florida 33136 Recruiting
Investigational Site Number: 8400010 Palmetto Bay Florida 33176 Recruiting
Investigational Site Number: 8400019 Tampa Florida 33609 Recruiting
Investigational Site Number: 8400018 Marietta Georgia 30060 Recruiting
Investigational Site Number: 8400005 Iowa City Iowa 52242 Recruiting
Investigational Site Number: 8400017 Boston Massachusetts 02115 Recruiting
Investigational Site Number: 8400012 Wyoming Michigan 49519 Recruiting
Investigational Site Number: 8400014 St Louis Missouri 63110 Recruiting
Investigational Site Number: 8400021 New York New York 10029 Recruiting
Investigational Site Number: 8400029 Queens Village New York 11428 Recruiting
Investigational Site Number: 8400002 Chapel Hill North Carolina 27514 Recruiting
Investigational Site Number: 8400013 Harrisburg Pennsylvania 17110 Recruiting
Investigational Site Number: 8400023 Houston Texas 77030 Recruiting
Investigational Site Number: 8400007 Ogden Utah 84405 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06975722, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 22, 2026 · Synced May 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06975722 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →